BioSyent's CEO is René Goehrum, appointed in May 1999, has a tenure of 27.17 years. total yearly compensation is CA$783.59K, comprised of 48.5% salary and 51.5% bonuses, including company stock and options. directly owns 5.75% of the company’s shares, worth $6.75M. The average tenure of the management team and the board of directors is 7.8 years and 10.5 years respectively.
Key information
René Goehrum
Chief executive officer
CA$783.6k
Total compensation
CEO salary percentage
48.54%
CEO tenure
27.2yrs
CEO ownership
5.7%
Management average tenure
7.8yrs
Board average tenure
10.5yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has René Goehrum's remuneration changed compared to BioSyent's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
CA$9m
Dec 31 2025
CA$784k
CA$380k
CA$9m
Sep 30 2025
n/a
n/a
CA$9m
Jun 30 2025
n/a
n/a
CA$8m
Mar 31 2025
n/a
n/a
CA$8m
Dec 31 2024
CA$762k
CA$370k
CA$7m
Sep 30 2024
n/a
n/a
CA$7m
Jun 30 2024
n/a
n/a
CA$7m
Mar 31 2024
n/a
n/a
CA$7m
Dec 31 2023
CA$748k
CA$357k
CA$6m
Sep 30 2023
n/a
n/a
CA$6m
Jun 30 2023
n/a
n/a
CA$5m
Mar 31 2023
n/a
n/a
CA$5m
Dec 31 2022
CA$681k
CA$343k
CA$5m
Sep 30 2022
n/a
n/a
CA$6m
Jun 30 2022
n/a
n/a
CA$6m
Mar 31 2022
n/a
n/a
CA$6m
Dec 31 2021
CA$681k
CA$329k
CA$6m
Sep 30 2021
n/a
n/a
CA$5m
Jun 30 2021
n/a
n/a
CA$4m
Mar 31 2021
n/a
n/a
CA$4m
Dec 31 2020
CA$649k
CA$325k
CA$4m
Sep 30 2020
n/a
n/a
CA$4m
Jun 30 2020
n/a
n/a
CA$5m
Mar 31 2020
n/a
n/a
CA$5m
Dec 31 2019
CA$497k
CA$310k
CA$4m
Compensation vs Market: René's total compensation ($USD551.97K) is about average for companies of similar size in the US market ($USD658.93K).
Compensation vs Earnings: René's compensation has been consistent with company performance over the past year.
CEO
René Goehrum (67 yo)
27.2yrs
Tenure
CA$783,588
Compensation
Mr. René C. Goehrum has been the Chairman of BioSyent Inc. since June 1999 and its Chief Executive Officer since May 1999 and also its President since June 2006. Mr. Goehrum is an experienced entrepreneur,...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
René Goehrum
Chairman
27.2yrs
CA$783.59k
5.75% $ 6.7m
Robert March
VP of Finance & CFO
7.8yrs
CA$409.22k
0.56% $ 662.2k
Joost van der Mark
Vice President of Corporate Development
7.8yrs
CA$327.21k
0.53% $ 622.4k
Marnie Mccormick
VP & GM
2.1yrs
CA$376.92k
0.14% $ 162.4k
Neelu Atwal
Director of Human Resources
7.5yrs
no data
0.21% $ 242.0k
7.8yrs
Average Tenure
Experienced Management: BIOY.F's management team is seasoned and experienced (7.8 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
René Goehrum
Chairman
30.5yrs
CA$783.59k
5.75% $ 6.7m
Joseph Arcuri
Independent Director
8.2yrs
CA$48.31k
0.12% $ 143.9k
Prakash Gowd
Independent Director
1.2yrs
CA$27.46k
no data
Peter Lockhard
Lead Independent Director
24.1yrs
CA$47.25k
1.57% $ 1.8m
Sara Elford
Independent Director
8.5yrs
CA$43.58k
0.15% $ 171.6k
Stephen Wilton
Independent Director
12.5yrs
CA$44.12k
0.065% $ 76.3k
10.5yrs
Average Tenure
62.5yo
Average Age
Experienced Board: BIOY.F's board of directors are seasoned and experienced ( 10.5 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/07 09:30
End of Day Share Price
2026/07/07 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
BioSyent Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.